Connect Biopharma Holdings Limited
CNTB · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $54,388 | $76,162 | $79,407 | $64,979 |
| - Cash | $40,632 | $78,232 | $110,174 | $106,007 |
| + Debt | $870 | $178 | $325 | $465 |
| Enterprise Value | $14,626 | -$1,892 | -$30,442 | -$40,563 |
| Revenue | $48 | $1,912 | $24,116 | $0 |
| % Growth | -97.5% | -92.1% | – | – |
| Gross Profit | $48 | $1,729 | $23,640 | -$482 |
| % Margin | 100% | 90.4% | 98% | – |
| EBITDA | -$13,253 | -$22,871 | $8,195 | -$28,372 |
| % Margin | -27,610.4% | -1,196.1% | 34% | – |
| Net Income | -$12,899 | -$23,217 | $7,649 | -$28,922 |
| % Margin | -26,872.9% | -1,214.2% | 31.7% | – |
| EPS Diluted | -0.23 | -0.42 | 0.14 | -0.52 |
| % Growth | 45.2% | -400% | 126.9% | – |
| Operating Cash Flow | -$12,591 | -$15,577 | -$7,974 | -$16,843 |
| Capital Expenditures | -$303 | -$312 | -$436 | -$8 |
| Free Cash Flow | -$12,894 | -$15,890 | -$8,410 | -$16,851 |